Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 320, Issue 1, Pages H200-H210
Publisher
American Physiological Society
Online
2020-11-21
DOI
10.1152/ajpheart.00601.2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy
- (2020) Nalinda B. Wasala et al. MOLECULAR THERAPY
- Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies
- (2020) Michelle L. Law et al. Journal of Clinical Medicine
- Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy
- (2019) Nandita Niranjan et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy
- (2019) Tatyana A. Meyers et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency-mediated chronically increased cardiac Ca2+ cycling in vivo
- (2018) Michelle L Law et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition
- (2018) Jun Tanihata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology
- (2018) Val A Fajardo et al. HUMAN MOLECULAR GENETICS
- Mini symposium: Duchenne Muscular Dystrophy–Pulmonary Function and Clinical Correlation in DMD
- (2018) Oscar H Mayer Paediatric Respiratory Reviews
- Cardiac Management of the Patient With Duchenne Muscular Dystrophy
- (2018) Sujatha Buddhe et al. PEDIATRICS
- Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and DysfunctionNovelty and Significance
- (2017) Zhen-Zhou Zhang et al. HYPERTENSION
- Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice
- (2017) Antanina Voit et al. Nature Communications
- Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart
- (2015) Ábel Perjés et al. BASIC RESEARCH IN CARDIOLOGY
- Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy
- (2015) A R Burr et al. CELL DEATH AND DIFFERENTIATION
- The Emerging Potential of the Apelin-APJ System in Heart Failure
- (2015) Jonathan R. Dalzell et al. JOURNAL OF CARDIAC FAILURE
- Cardiac Specific Expression of Threonine 5 to Alanine Mutant Sarcolipin Results in Structural Remodeling and Diastolic Dysfunction
- (2015) Mayilvahanan Shanmugam et al. PLoS One
- Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function
- (2014) N.V. Ermolova et al. NEUROMUSCULAR DISORDERS
- Apelin Increases Cardiac Contractility via Protein Kinase Cε- and Extracellular Signal-Regulated Kinase-Dependent Mechanisms
- (2014) Ábel Perjés et al. PLoS One
- Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy
- (2013) Nalinda B. Wasala et al. HUMAN MOLECULAR GENETICS
- Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy
- (2013) Joel S. Schneider et al. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
- (2013) Wang Wang et al. Journal of the American Heart Association
- Ablation of sarcolipin results in atrial remodeling
- (2012) Lai-Hua Xie et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Emerging drugs for Duchenne muscular dystrophy
- (2012) Vinod Malik et al. EXPERT OPINION ON EMERGING DRUGS
- Progress in gene therapy of dystrophic heart disease
- (2012) Y Lai et al. GENE THERAPY
- AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy
- (2012) Brian Bostick et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The Paradox of Muscle Hypertrophy in Muscular Dystrophy
- (2012) Joe N. Kornegay et al. Physical Medicine and Rehabilitation Clinics of North America
- Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy
- (2011) Daniel P. Judge et al. American Journal of Cardiovascular Drugs
- Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle
- (2011) Louise H. Jørgensen et al. AMERICAN JOURNAL OF PATHOLOGY
- SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice
- (2011) Jin-Hong Shin et al. Journal of Translational Medicine
- Impaired respiratory function in mdx and mdx/utrn+/− mice
- (2011) Ping Huang et al. MUSCLE & NERVE
- Cardiomyopathy of duchenne muscular dystrophy: Current understanding and future directions
- (2011) Christopher F. Spurney MUSCLE & NERVE
- Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice
- (2011) Lawrence T. Bish et al. PLoS One
- Gender influences cardiac function in the mdx model of duchenne cardiomyopathy
- (2010) Brian Bostick et al. MUSCLE & NERVE
- Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes
- (2008) Chen Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiac Expression of a Mini-dystrophin That Normalizes Skeletal Muscle Force Only Partially Restores Heart Function in Aged Mdx Mice
- (2008) Brian Bostick et al. MOLECULAR THERAPY
- Dystrophin-deficient cardiomyopathy in mouse: Expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart
- (2008) Christopher F. Spurney et al. NEUROMUSCULAR DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now